Changing the Way We Look at Tissue

HistoRx offfers the first advanced histopathology analysis platform, using the company’s proprietary AQUA® technology capable of measuring biomarker concentration with sub-cellular resolution in tissue sections. AQUA® analysis of biomarkers generates more precise, efficient, and cost-effective answers about the safety and effectiveness of new therapeutics in development and provides the foundation for companion diagnostic tests. HistoRx services are used throughout basic biomedical research, preclinical and clinical drug development studies, facilitating the efforts of pharmaceutical and biotechnology companies to improve efficiency and effectiveness throughout drug development to bring new targeted therapies to the market. HistoRx pursues internal programs to develop proprietary standard-of-care diagnostics that offer substantial improvements over existing immunohistochemistry-based tests. HistoRx provides academic researchers at leading institutions access to AQUA® technology for use exclusively in noncommercial research.